ArticleVeterinary dermatology2025

Efficacy and field safety of ilunocitinib for the control of atopic dermatitis in client-owned dogs: A multicentre, double-masked, randomised, placebo-controlled clinical trial.

Sophie Forster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.